This finding is consistent with our primary transcriptomic analyses and in-house serum validation, both of which demonstrated elevated ABCA1 levels in ALS, thereby reinforcing its reliability as a reproducible peripheral biomarker across independent cohorts. The gene discussed is ABCA1; the disease is amyotrophic lateral sclerosis.